Evidence map›Paper›PMID 33707173›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2021

Leucoselect Phytosome Modulates Serum Eicosapentaenoic Acid, Docosahexaenoic Acid, and Prostaglandin E3 in a Phase I Lung Cancer Chemoprevention Study.

Jenny T Mao, Bingye Xue, Sili Fan, Patricia Neis, Clifford Qualls, Larry Massie, Oliver Fiehn

Open access · bronzeAbstract readClinical Trial, Phase I
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jenny T MaoPulmonary, Critical Care and Sleep Section, New Mexico Veterans Administration Health Care System, and University of New Mexico, Albuquerque, New Mexico. Jenny.Mao@va.gov.
Bingye XuePulmonary, Critical Care and Sleep Section, New Mexico Veterans Administration Health Care System, and University of New Mexico, Albuquerque, New Mexico.
Sili FanUC Davis Genome Center, Davis, California.
Patricia NeisPulmonary, Critical Care and Sleep Section, New Mexico Veterans Administration Health Care System, and University of New Mexico, Albuquerque, New Mexico.
Clifford QuallsBiostatistics, Biomedical Research Institute of New Mexico, New Mexico Veterans Administration Health Care System, and University of New Mexico, Albuquerque, New Mexico.
Larry MassiePathology and Clinical Laboratory Services, New Mexico Veterans Administration Health Care System, and University of New Mexico, Albuquerque, New Mexico.
Oliver FiehnUC Davis Genome Center, Davis, California.ORCID 0000-0002-6261-8928
New Mexico VA Health Care System · USUniversity of California, Davis · US

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
West Coast Metabolomics Center for Compound IdentificationU2CES030158 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KIND, TOBIAS · 2018 to 2021
$4.1M
Feasibility of grape seed extract for lung cancer chemopreventionR21CA173211 · NCI · BIOMEDICAL RESEARCH INSTITUTE OF NEW MEX · PI MAO, JENNY T · 2013 to 2015
$312k
The Effects of Grape Seed Extract Against Lung CancerI01BX002258 · VA · ALBUQUERQUE VA MEDICAL CENTER · PI MAO, JENNY T · 2014 to 2016
–
Combinations of Grape Seed and Milk Thistle Extracts Against LungI01BX004092 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI MAO, JENNY T · 2019 to 2025
–
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung CancerI01CX002028 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI MAO, JENNY T · 2021 to 2025
–
BLRD VA I01 BX002258BLRD VA I01 BX004092CSRD VA I01 CX002028NCI NIH HHS P30 CA118100NCI NIH HHS R21 CA173211NIEHS NIH HHS U2C ES030158
6 · The paper itself

Abstract

Grape seed procyanidin extract (GSE) has been shown to exert antineoplastic properties in preclinical studies. Recently, we reported findings from a modified phase I, open-label, dose escalation clinical study conducted to evaluate the safety, tolerability, MTD, and potential chemopreventive effects of leucoselect phytosome, a standardized GSE complexed with soy phospholipids to enhance bioavailability, in heavy active and former smokers. Three months of leucoselect phytosome treatment significantly decreased bronchial Ki-67 labeling index (LI), a marker of cell proliferation on the bronchial epithelium. Because GSE is widely used as a supplement to support cardiovascular health, we evaluate the impact of oral leucoselect phytosome on the fasting serum complex lipid metabolomics profiles in our participants. One month of leucoselect phytosome treatment significantly increased eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the omega-3 polyunsaturated fatty acids (n-3 PUFA) with well-established anticancer properties. Leucoselect phytosome also significantly increased unsaturated phosphatidylcholines (PC), likely from soy phospolipids in the phytosome and functioning as transporters for these PUFAs. Furthermore, 3-month leucoselect phytosome treatment significantly increased serum prostaglandin (PG) E

Indexed as

Administration, OralAlprostadilBronchiCell Line, TumorDocosahexaenoic AcidsEicosapentaenoic AcidGrape Seed ExtractHumansLung NeoplasmsTreatment OutcomeAlprostadilDocosahexaenoic AcidsEicosapentaenoic AcidGrape Seed Extractleucoselect phytosomeprostaglandin E3

Identifiers

PMID33707173
PMCPMC8225569
OpenAlexW3134999759

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.